جستجوی استاد راهنمای دانشگاهی

Sarah Lockie serves as Research Development Manager at Monash University's School of Biomedical Sciences, where she also completed her PhD in 2012 through a joint supervision arrangement with the University of Cincinnati, OH, USA. Her research career spans over a decade with 38 documented research outputs and leadership on 9 research projects, demonstrating sustained scholarly activity in metabolic neuroscience and related fields. Dr. Lockie's research interests center on metabolic neuroscience with particular focus on cancer cachexia, neural control of feeding, and ghrelin resistance in obesity. Her work integrates multiple disciplines including endocannabinoid signaling, glucose metabolism, and appetite regulation pathways. She investigates specialized neural populations including AgRP neurons, GFRAL neurons, and examines the role of GDF15, GLP-1, and glucagon in metabolic homeostasis. Her current research particularly emphasizes loss of appetite mechanisms in cancer cachexia, representing a critical area of translational neuroscience with significant clinical implications. Her recent publications reveal a strong trend toward understanding the neural circuitry connecting metabolic states with cognitive and emotional processing, particularly examining how stress affects appetite regulation through specific neurocircuitry between the prefrontal cortex and hypothalamus. This work bridges basic neuroscience with clinical applications for cancer-related appetite disorders. Harold Mitchell ECR travel fellowship (2018) Vice Chancellor's Commendation for Doctoral Thesis Excellence (2012) Young Investigator Prize (2015) Dr. Lockie has secured multiple research grants including the Endocrine Society of Australia Post Doctoral Award (2020-2021), BSN Research visit grant (2019), and currently leads the NHMRC-funded project 'Targeting the brain and sympathetic nervous system to improve outcomes in cancer cachexia' (2022-2025). She has also contributed as a Chief Investigator on the NHMRC Equipment Grant for Danish Myo-Technology (2023-2024). Her collaborative network includes prominent researchers such as Z. Andrews, R. Stark, and R. Clarke, reflecting strong interdisciplinary connections within metabolic neuroscience. Her research operates at the intersection of metabolic neuroscience and clinical applications, with particular emphasis on translating basic findings about neural appetite regulation into potential therapeutic approaches for cancer cachexia. Her work contributes to UN Sustainable Development Goals related to good health and well-being through its focus on improving outcomes for cancer patients experiencing appetite loss.

• Metabolic neuroscience
• Cancer cachexia
• Neural control of feeding
• +۶ مورد دیگر

Associate Professor Atul Malhotra is a senior neonatologist at Monash Newborn, Monash Children's Hospital, and a research academic in the Department of Paediatrics, Monash University. He is the co-director of the Newborn Cell Therapies Group at the School of Clinical Sciences at Monash Health and leads multiple active research projects. He is the current recipient of an NHMRC Emerging Leadership Fellowship and has secured over $20 million in research funding. Education: PhD in Basic Science, Monash University (2014–2019) FRACP in Paediatrics-Neonatal-Perinatal Medicine, Royal Australasian College of Physicians (2005–2009) DNB in Paediatrics, National Board of Examinations (2002) MD in Paediatrics, University of Delhi (1999–2002) MBBS in Medicine, University of Delhi (1993–1997) His research focuses on improving respiratory and neurological outcomes in high-risk infants. He is passionate about neurodevelopment after high-risk birth and leads the Early Neurodevelopment Clinic at Monash Children's Hospital. His work spans clinical trials, evidence-based neonatology, fetal growth restriction, and regenerative medicine. He also explores medical device innovation and AI in newborn monitoring through collaboration with Monash's Faculty of Engineering. His recent publications highlight pioneering work in cord blood cell therapy, perinatal brain injury, pandemic impacts on preterm birth, and vaccine safety in preterm infants. These reflect a strong trend in translational neonatal research, integrating clinical practice with laboratory science and public health. Scientific Awards and Honors: NHMRC Emerging Leadership Fellowship ANZNN Neonatal Research Award (2019) Best of Stem Cells Translational Medicine 2018 (2019) Cerebral Palsy Alliance Emerging Researcher (2020) Eric Burnard Fellowship (2018) Best Poster, Monash Health Research Week (2013) He has been instrumental in securing major research grants, including leadership of the trial Cell Therapies for Newborn Infants: Translating Promise to Benefits , and serves as Principal Investigator on multiple active projects. He has advised on national policy through roles in the Royal Australasian College of Physicians and is actively mentoring the next generation of researchers, accepting PhD students via SupervisorConnect. He is the co-founder of the global interprofessional education initiative ONE-Sim Education and served as inaugural Co-Chair of Monash Children's Hospital's Simulation Centre. He leads the Biomedical Signal Processing Lab in collaboration with Monash Engineering, aiming to improve neonatal monitoring. He is also co-director of the Newborn Cell Therapies Group , advancing regenerative therapies from bench to bedside. His work contributes to UN Sustainable Development Goals in health and education.

• Neonatology
• Neurodevelopment
• Regenerative Medicine
• +۱۲ مورد دیگر

Md Ezharul Hoque Chowdhury is a Professor at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, where he specializes in biomedical science and nanomedicine. He earned his Doctor of Engineering from Tokyo Institute of Technology in 2003 and held research and academic positions there before joining Monash in 2011 as a Senior Lecturer, later promoted to Associate Professor in 2013 and currently serving as Professor. His research centers on innovative drug and gene delivery systems, particularly the development of pH-sensitive inorganic nanoparticles for cancer therapy. These smart nanocarriers offer significant advantages such as high stability, controlled drug release, minimal toxicity, and enhanced therapeutic efficacy at drastically reduced drug doses. His work has elucidated intracellular delivery mechanisms and cellular processing of nanoparticle components, while also enabling precise control over particle size and surface functionalization for both passive and active targeting in tumors. The recent publications highlight a strong focus on breast and lung cancer, with themes including siRNA delivery, tumor suppressor gene therapy (BRCA1/BRCA2), overcoming multi-drug resistance, and exploring novel biological targets like alpha-synuclein. His research spans nanomaterials, molecular oncology, proteomics, and translational nanomedicine, reflecting a multidisciplinary approach to cancer treatment. Scientific Awards: Monash University School of Pharmacy Pilot Research Grant (2021) Prof. Chowdhury has secured 25 research grants as principal investigator and is a co-inventor of seven international patents (US, Japan, Malaysia), several of which are in the commercialization pipeline. He has published over 100 original articles and authored a complete book. His collaborative research includes multiple international projects focused on cancer signaling, chemoresistance, and nano-therapeutics. He leads a research team advancing the frontier of nanomedicine, particularly in developing multifunctional nanoparticles capable of delivering drug-gene-RNA cocktails to combat cancer progression and resistance. His lab's work bridges engineering, biology, and medicine, aiming to transition promising pre-clinical results into clinical success.

• Nanomedicine
• Biomedical Science
• Cancer Therapeutics
• +۱۳ مورد دیگر

Kalin Stefanov is an ARC DECRA Fellow and Research Fellow in the Department of Human Centred Computing at Monash University. He holds a PhD in Computer Science from KTH Royal Institute of Technology and an MSc in Artificial Intelligence from the University of Amsterdam. His research focuses on Affective Computing, exploring systems that recognize and simulate human affects, with applications in social robotics, neurodiverse communication, and multimodal interaction. He has led projects on sign language translation and large-scale deepfake detection datasets. Key collaborations include work at the University of Southern California’s Institute for Creative Technologies and National Institute of Informatics. He has received accolades such as the Discovery Early Career Researcher Award (2023) and Best Paper Awards (2019, 2024). His research also contributes to UN SDG 4 (Quality Education) through accessible technologies for neurodiverse groups and visually impaired learners. Projects include the 'Active Generation of fingerspelling in Australian Sign Language' and 'Research Towards automated Australian Sign Language translation,' funded by the Australian Research Council. Stefanov’s work spans AI ethics, multimodal data platforms (e.g., OpenSense), and systems for social signal processing in human-robot interaction.

• Affective Computing
• Artificial Intelligence
• Accessible Computing
• +۵ مورد دیگر

YUN Zhao is a Research Fellow in the Department of Data Science & AI at Monash University, contributing to cutting-edge research at the intersection of neuroscience, machine learning, and biomedical engineering. Their work involves advanced computational modeling of brain dynamics, with applications in epilepsy, anesthesia, and neurophysiological imaging. Research interests focus on computational neuroscience , neuroinformatics , and machine learning . Key areas include nonlinear brain modeling, spatiotemporal inference, and optimization of signal processing techniques such as Kalman filters. The research leverages deep learning (e.g., LSTM networks) for reconstructing brain state spaces and analyzing neural oscillations. The recent publications demonstrate a strong trend in inference-based neuroimaging and time-resolved analysis of whole-brain models, applying these methods to clinical neuroscience challenges like focal epilepsy and resting-state alpha rhythms. Much of the work integrates biophysical modeling with data-driven approaches for improved understanding of brain states. YUN Zhao collaborates with leading researchers including David B. Grayden, Mark J. Cook, and Levin Kuhlmann, indicating integration into a high-impact neuroengineering research network at Monash. While no formal advising or grant leadership is mentioned, the volume and quality of recent peer-reviewed outputs suggest active engagement in funded research projects. The research contributes to UN Sustainable Development Goal 3 (Good Health and Well-being) through innovations in neurological disorder diagnosis and brain monitoring technologies.

• Neuroinformatics
• Computational Neuroscience
• Brain Modeling
• +۷ مورد دیگر

Dr. Claire Foldi is an Associate Professor in the Department of Physiology at the Monash Biomedicine Discovery Institute (BDI), Monash University, where she leads the Neural Mechanisms of Eating Disorders laboratory. She is actively engaged in research, teaching, and supervising students in the field of neuroscience and eating disorders. Institution: Monash University School: Faculty of Medicine, Nursing and Health Sciences Department: Department of Physiology Research Lab: Neural Mechanisms of Eating Disorders Laboratory Dr. Foldi completed her PhD in Behavioural Neuroscience at the Queensland Brain Institute in 2012, followed by postdoctoral training at the Karolinska Institutet in Sweden. She joined Monash University in 2015 and has since established a robust research program focused on the neurobiological basis of psychiatric diseases, particularly anorexia nervosa. Her research interests center on understanding the neural circuitry involved in feeding behavior, body weight regulation, and the neurochemical underpinnings of eating disorders. She is particularly interested in response heterogeneity across biological and clinical levels and is pioneering work on the therapeutic potential of psilocybin for anorexia nervosa. Her research integrates animal models, molecular neurobiology, and translational frameworks to bridge gaps between preclinical findings and clinical applications. The most recent articles highlight a strong trend toward psychedelic therapeutics, gut-brain axis involvement, neurotransmitter interactions (especially serotonin and dopamine), and transdiagnostic approaches to compulsive behaviors in eating disorders. Her publications appear in high-impact journals such as Nature Reviews Neuroscience , Trends in Pharmacological Sciences , and International Journal of Eating Disorders . Dr. Foldi has received notable scientific recognition, including: CASS Foundation Travel Award (2018) Harold Mitchell Foundation Fellowship (2020) She is actively involved in grants and research projects, serving as Primary Chief Investigator on multiple NHMRC-funded studies, including projects on psilocybin therapy and cortical control of feeding circuits. She also supervises non-HDR students and contributes to teaching in the Integrative Neuroscience and Masters of Biomedical and Health Sciences programs. Her lab is supported by major funding bodies such as the NHMRC, Rebecca L Cooper Medical Research Foundation, and the British Society for Neuroendocrinology. The Foldi Lab fosters a collaborative, interdisciplinary environment focused on advancing understanding and treatment of eating disorders through cutting-edge neuroscience.

• Neurobiology of Eating Disorders
• Anorexia Nervosa
• Animal Models of Psychiatric Disease
• +۱۲ مورد دیگر

Jeff Luo is a Research Fellow in the Department of Medicinal Chemistry at Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences. His research focuses on the design and characterization of bioactive peptides and molecular imaging techniques, contributing to drug discovery and understanding protein aggregation processes. Research Interests: Dr. Luo's work spans medicinal chemistry and chemical biology, with emphasis on peptide engineering, cell permeability, and nanoscale imaging. He investigates how modified peptides can penetrate cells and localize in nuclei, alongside visualizing amyloid assembly relevant to neurodegenerative diseases. His interdisciplinary approach bridges synthetic chemistry and biological evaluation. The recent publication trend shows strong engagement in peptide therapeutics and super-resolution imaging , indicating a focus on both molecular design and advanced analytical methods. These efforts align with biomedical applications in neurology and oncology. No scientific awards or fellowships were mentioned in the source text. Advising and Grants: There is no public information available regarding student supervision, grant funding, or project leadership. However, his collaborative publications suggest active participation in team-based research projects. Labs and Research Teams: Dr. Luo is part of a research network at Monash University involving experts in peptide science and imaging technologies. His collaborations include researchers such as A. Kaur, Y. H. Lau, and T. Huang, indicating integration into a dynamic, multidisciplinary group focused on chemical biology and pharmaceutical innovation.

• Medicinal Chemistry
• Peptide Science
• Chemical Biology
• +۷ مورد دیگر

Isabelle Lucet is an Adjunct Senior Lecturer in the Department of Biochemistry & Molecular Biology at Monash University, within the Faculty of Medicine, Nursing and Health Sciences. Her research focuses on structural biology, drug design, and molecular mechanisms of cellular processes relevant to cancer, plant immunity, and microbial pathogenesis. She has been a Primary Chief Investigator on an NHMRC-funded project (2004–2007) studying JAK/ABL kinases for drug design applications. Her expertise aligns with UN Sustainable Development Goals, particularly in advancing health and well-being through biomedical research. Key research areas include cancer cell invasion dynamics, plant immune receptor activation, and structural studies of bacterial and viral proteins. Notable projects involve collaborations on EphB6-ephrinB1 signaling in cancer metastasis, ZAR1 immune receptor function in plants, and viral kinase regulation mechanisms. Recent publications highlight her interdisciplinary work in structural biology, proteomics, and pathogen-host interactions. She has contributed over 58 peer-reviewed articles across diverse topics such as neuroprotection mechanisms, mycobacterial cell wall synthesis, and alphavirus replication strategies.

• Biochemistry
• Molecular Biology
• Structural Biology
• +۵ مورد دیگر

Edwina McGlinn is a Research Professor at the Australian Regenerative Medicine Institute (ARMI) within Monash University. Her research focuses on RNA biology, particularly microRNAs, and their roles in gene regulation, developmental processes, and disease. She leads studies on limb formation, genetic networks, and the functional analysis of microRNAs in vivo. McGlinn has pioneered technologies to assess microRNA function during development, contributing to understanding how genetic pathways influence cell identity and disease mechanisms. Research Projects: In utero correction of craniofacial malformations (2025–2028) MicroRNA targeting to enhance haematopoietic stem cell function (2022–2025) Trunk-to-tail transition regulatory architecture Key Research Interests: MicroRNA regulation of gene expression and disease Developmental genetics of limb formation and axial patterning Epigenetic mechanisms in Hox gene regulation Awards & Recognition: 2023 ANZSCDB Emerging Leader Award for contributions to cell and developmental biology 2020 Vice-Chancellor's Diversity and Inclusion Award (shared) Lab & Collaborations: Her lab employs cutting-edge genetic and imaging techniques, collaborating on projects such as fluorescent microscopy advancements and 3D light-sheet microscopy. Research contributes to UN SDGs related to health and well-being through regenerative medicine and disease modeling.

• RNA Biology
• Developmental Biology
• Gene Regulation
• +۵ مورد دیگر

Shaun Cloherty is a Lecturer in the Department of Biomedical Engineering at RMIT University's School of Engineering. He holds a BE (Hons) in Aerospace Avionics from Queensland University of Technology and a PhD in Biomedical Engineering from the University of New South Wales. His research focuses on systems neuroscience, integrating experimental and computational methods to understand neural coding, information processing in the brain, and the neural basis of perception and behavior. Cloherty has held research positions at UNSW, Australian National University, National Vision Research Institute, and Monash University. His teaching interests include undergraduate courses such as Image Processing, Computer Architecture, and Biomedical Signal Analysis, alongside postgraduate courses in Image Systems Engineering. He is open to supervising Masters and PhD students in areas like neural prosthetics, retinal implantation safety, and motor imagery recovery. Cloherty's research spans topics including retinal prosthesis safety, visual processing in primates, and the application of virtual reality in post-stroke rehabilitation. His work has been published in journals like *Progress in Biomedical Engineering* and *Journal of Neuroscience*. He actively contributes to collaborative projects and maintains a GitHub profile for software development related to mission control training and biomedical systems. His research projects include investigating motor imagery and VR for stroke recovery, developing chronic neural electrode arrays, and optimizing solar cell light-trapping designs. Cloherty's interdisciplinary approach bridges engineering and neuroscience, with a focus on translational applications in health technology.

• Systems Neuroscience
• Neural Coding and Information Processing
• Biomedical Engineering
• +۴ مورد دیگر

Fernando Marmolejo Ramos is a Lecturer in Psychology at Flinders University's College of Education, Psychology and Social Work. He holds external roles including Adjunct Research Fellow at University of South Australia (2024–present) and Visiting Research Fellow at University of Adelaide (2011–present). His research focuses on embodied cognition, AI, statistical modeling, and open science practices. Education: PhD in Psychology (University of Adelaide, 2007–2011), MSc (University of Ballarat, 2005–2007), and BSc (Universidad del Valle, 1997–2003). Research interests include language processing in neurodegenerative disorders, machine learning applications in healthcare, and AI in education. He has secured grants totaling over $1M AUD for projects like statistical infection detection algorithms using wearables and AI-enhanced learning tools. Recent awards include CSIRO On Prime Innovation Reward (2024) and Flinders University Teaching Award (2025). He reviews for journals like Neuroscience and Biobehavioral Reviews and serves on grant review panels for national research councils in multiple countries.

• Experimental Psychology
• Embodied Cognition
• Artificial Intelligence
• +۷ مورد دیگر

Michelle Halls is an Associate Professor (Research) in the Drug Discovery Biology Theme at Monash Institute of Pharmaceutical Sciences, Monash University. Her research focuses on understanding how cell signalling pathways are spatially organized, particularly through G protein-coupled receptors (GPCRs), to drive physiological and pathological processes. She leads interdisciplinary teams developing targeted therapeutics that exploit subcellular receptor localization for enhanced efficacy. Key Affiliations: Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences Viertel Senior Medical Research Fellow (2020-2025) NHMRC RD Wright Career Development Fellow (2014-2019) NHMRC CJ Martin Overseas Biomedical Fellow (2008-2013) Research Interests: Cells use GPCRs to translate diverse stimuli into specific responses via localized signalling networks. Halls' team uses microscopy, mass spectrometry, and drug delivery to study how GPCRs' spatial organization influences cancer metastasis, pain transmission, and hormone signaling. Key projects include targeting metastatic breast cancer via β2-adrenoceptor pathways and developing endosome-targeted opioids for prolonged pain relief. Awards: ASCEPT Achievement Award (2024) British Pharmacological Society Geoffrey Burnstock Prize (2023) Faculty of Pharmacy Excellence in Research Future Leader Award (2019) Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Investigator Award (2010) Grants & Collaborations: ARC-funded project on nuclear hormone receptors (2024-2027) NHMRC grants targeting neurofibromatosis and breast cancer (2021-2024) Equity Trustees project on GPCR signalling networks (2020-2025) Labs & Teams: Directs the Spatial Organisation of Signalling Laboratory, collaborating with global teams on GPCR structural biology and drug development.

• Cell Signalling
• GPCR Biology
• Drug Discovery
• +۴ مورد دیگر

Dr. Sobhan Salari Shahrbabaki is a Research Fellow at Flinders University within the College of Medicine and Public Health . He works in the Flinders Health and Medical Research Institute and Medical Device Research Institute , focusing on cardiac electrophysiology under Professor Anand Ganesan's lab. Education : PhD (2020) - The University of Adelaide Graduate Certificate in Electrical Engineering (2013) - University of Queensland Bachelor of Biomedical Engineering (2006) - Sahand University of Technology, Iran His research bridges biomedical engineering and computational cardiology through innovative signal processing techniques. Key areas include: Arrhythmia dynamics and prediction Power-law modeling of cardiac events Real-time electrophysiology software Non-invasive cardiovascular monitoring Sleep-cardiovascular interactions Recent publications demonstrate cross-disciplinary integration of machine learning and clinical cardiology for developing: Arrhythmia avalanche analysis tools Gestational disorder screening methods Ex vivo cardiac pacing models Scientific Contributions : 2023: CIA on Tom Simpson Trust Equipment Fund, National Heart Foundation of Australia Peer-reviewed articles in European Heart Journal , Chest , Heart Rhythm , and International Journal of Cardiology Current affiliations: Research Associate, Flinders University Casual Part-time Academic Researcher (2020-2022), The University of Adelaide Collaborator in multiple international cardiovascular research networks

• Signal Processing
• Biomedical Data Analysis
• Machine Learning
• +۲ مورد دیگر

Dr Siyuan Chen is a Lecturer at the School of Electrical Engineering and Telecommunications , UNSW Sydney. Her research focuses on physiological computing , particularly eye activity analysis for mental state recognition using wearable technology . She has contributed to signal processing and machine learning methodologies for non-invasive cognitive load and task transition detection. Ph.D. in Electrical Engineering (UNSW Sydney) M.E. in Microelectronics (RMIT University) Research Intern, NII Tokyo Research Fellow, University of Melbourne Research Visitor, INRIA France Chen's research investigates eye behavior through infrared video datasets and multimodal sensor signals. Her work addresses physiological computing for applications in human-computer interaction , wearable mental state analysis , and biomedical signal processing . Key contributions include the IREye4Task dataset and novel methods for blink-saccade synchronization and pupillary response analysis . Recent publications demonstrate trends in wearable eye tracking using acoustic sensors, low-power facial expression tracking , and event-based task transition detection . Her work spans both journal and conference venues including IEEE Transactions, ACM, and INTERSPEECH. NICTA Postgraduate Scholarship (2011-2013) Commercialization Training Scheme Scholarship (2012) Australia Endeavor Fellowship (2015) $711K US Army grant for wearable behavioral signal modeling (2019) Chen contributes to teaching in electronics , signal processing , and engineering ethics , covering courses from first-year design to postgraduate leadership modules. She serves as a topic editor for Frontiers in Computer Science special issues.

• Physiological Computing
• Eye Activity Analysis
• Human-Computer Interaction
• +۳ مورد دیگر

Dr. James Kesby is a Lecturer at the School of Biomedical Sciences , University of Queensland, with a focus on developmental neurobiology and psychosis research. He is affiliated with the Queensland Centre for Mental Health Research and leads a cross-species research program connecting corticostriatal circuitry to decision-making deficits in schizophrenia. Research Interests: Corticostriatal circuitry in psychosis Decision-making and cognitive flexibility Translational rodent-human models Dopamine and schizophrenia Developmental neurobiology Neurochemical mechanisms of cognitive deficits Article Trends (2025–2023): Recent studies focus on corticostriatal interactions in reversal learning, dopamine modulation in cognitive flexibility, and translational paradigms for psychosis. Articles from 2022–2021 extend findings to clinical schizophrenia subtypes and novel therapeutic targets like GLP-1RAs. Education and Academic History: Dr. Kesby completed his PhD in 2010 at University of Queensland with Prof. Darryl Eyles and A/Prof. Thomas Burne, studying developmental vitamin D deficiency and dopamine systems in schizophrenia models. Research Infrastructure: His work operates within the Developmental Neurobiology Research Stream at the Queensland Centre for Mental Health Research, integrating clinical and preclinical methodologies.

• Cognitive Neuroscience
• Psychiatry
• Neurobiology
• +۵ مورد دیگر